Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Inflammasomes | 18 | 2023 | 333 | 2.960 |
Why?
|
Caspase 8 | 8 | 2025 | 64 | 2.920 |
Why?
|
Inflammation | 16 | 2025 | 1138 | 2.040 |
Why?
|
Plague | 7 | 2018 | 23 | 2.010 |
Why?
|
Immunity, Innate | 11 | 2020 | 794 | 2.000 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 4 | 2025 | 81 | 1.660 |
Why?
|
Yersinia pestis | 8 | 2016 | 33 | 1.610 |
Why?
|
Cell Death | 7 | 2025 | 280 | 1.570 |
Why?
|
Toll-Like Receptor 4 | 21 | 2023 | 344 | 1.570 |
Why?
|
Adjuvants, Immunologic | 8 | 2015 | 228 | 1.370 |
Why?
|
Signal Transduction | 37 | 2025 | 3020 | 1.320 |
Why?
|
Macrophages | 15 | 2025 | 1039 | 1.290 |
Why?
|
Pyroptosis | 3 | 2025 | 32 | 1.290 |
Why?
|
Receptors, Cell Surface | 20 | 2005 | 431 | 1.240 |
Why?
|
Membrane Glycoproteins | 19 | 2005 | 669 | 1.170 |
Why?
|
Carrier Proteins | 8 | 2018 | 705 | 1.120 |
Why?
|
Interleukin-1beta | 12 | 2023 | 262 | 1.100 |
Why?
|
Animals | 78 | 2025 | 20579 | 1.040 |
Why?
|
Mice | 60 | 2025 | 10802 | 1.030 |
Why?
|
Myeloid Differentiation Factor 88 | 12 | 2014 | 204 | 1.000 |
Why?
|
Bacterial Outer Membrane Proteins | 2 | 2016 | 125 | 0.970 |
Why?
|
Mice, Knockout | 27 | 2025 | 2097 | 0.940 |
Why?
|
Lipid A | 6 | 2015 | 66 | 0.930 |
Why?
|
Interleukin-18 | 9 | 2020 | 73 | 0.910 |
Why?
|
Toll-Like Receptor 2 | 16 | 2014 | 223 | 0.900 |
Why?
|
Toll-Like Receptors | 25 | 2020 | 431 | 0.900 |
Why?
|
Yersinia Infections | 3 | 2025 | 10 | 0.860 |
Why?
|
RNA Splicing | 1 | 2025 | 161 | 0.860 |
Why?
|
NLR Family, Pyrin Domain-Containing 3 Protein | 14 | 2023 | 257 | 0.850 |
Why?
|
Lipopolysaccharides | 19 | 2020 | 644 | 0.850 |
Why?
|
Apoptosis Regulatory Proteins | 6 | 2018 | 150 | 0.780 |
Why?
|
Mice, Inbred C57BL | 28 | 2025 | 3387 | 0.780 |
Why?
|
RNA-Binding Proteins | 2 | 2025 | 432 | 0.770 |
Why?
|
Intracellular Signaling Peptides and Proteins | 5 | 2019 | 336 | 0.770 |
Why?
|
Host-Pathogen Interactions | 3 | 2018 | 261 | 0.740 |
Why?
|
Saponins | 3 | 2015 | 29 | 0.710 |
Why?
|
Dendritic Cells | 10 | 2020 | 523 | 0.710 |
Why?
|
AIDS Vaccines | 3 | 2015 | 70 | 0.660 |
Why?
|
Protein Kinases | 2 | 2023 | 152 | 0.610 |
Why?
|
Sugars | 1 | 2018 | 5 | 0.610 |
Why?
|
I-kappa B Kinase | 1 | 2018 | 50 | 0.600 |
Why?
|
Bacterial Proteins | 5 | 2019 | 769 | 0.600 |
Why?
|
Lipopolysaccharide Receptors | 11 | 2020 | 144 | 0.590 |
Why?
|
Receptors, Pattern Recognition | 1 | 2018 | 36 | 0.590 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2018 | 82 | 0.590 |
Why?
|
Virulence | 3 | 2016 | 195 | 0.570 |
Why?
|
Bacterial Infections | 2 | 2023 | 148 | 0.550 |
Why?
|
Pyrin | 1 | 2016 | 7 | 0.540 |
Why?
|
Bacterial Secretion Systems | 1 | 2016 | 10 | 0.530 |
Why?
|
Adaptor Proteins, Vesicular Transport | 3 | 2014 | 81 | 0.530 |
Why?
|
Cells, Cultured | 16 | 2019 | 2154 | 0.480 |
Why?
|
Receptors, Interleukin | 1 | 2014 | 38 | 0.460 |
Why?
|
Lymphocyte Antigen 96 | 6 | 2009 | 47 | 0.450 |
Why?
|
Cytokines | 12 | 2023 | 933 | 0.430 |
Why?
|
Drosophila Proteins | 10 | 2003 | 688 | 0.420 |
Why?
|
Eicosapentaenoic Acid | 1 | 2013 | 16 | 0.420 |
Why?
|
Docosahexaenoic Acids | 1 | 2013 | 31 | 0.420 |
Why?
|
Virulence Factors | 2 | 2019 | 85 | 0.400 |
Why?
|
NF-kappa B | 8 | 2018 | 469 | 0.360 |
Why?
|
Macrophages, Peritoneal | 6 | 2014 | 77 | 0.310 |
Why?
|
Receptors, Immunologic | 5 | 2016 | 177 | 0.310 |
Why?
|
Phosphate-Binding Proteins | 2 | 2019 | 19 | 0.310 |
Why?
|
Diabetes Mellitus, Experimental | 3 | 2018 | 198 | 0.310 |
Why?
|
Apoptosis | 6 | 2023 | 1066 | 0.310 |
Why?
|
Gene Expression Regulation | 6 | 2020 | 1611 | 0.310 |
Why?
|
RNA, Double-Stranded | 3 | 2011 | 111 | 0.300 |
Why?
|
Antigens, Differentiation | 4 | 2004 | 138 | 0.300 |
Why?
|
Streptococcus agalactiae | 4 | 2014 | 79 | 0.290 |
Why?
|
Humans | 51 | 2024 | 62653 | 0.290 |
Why?
|
Toll-Like Receptor 3 | 4 | 2013 | 66 | 0.280 |
Why?
|
Plague Vaccine | 1 | 2006 | 5 | 0.270 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2009 | 619 | 0.260 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 690 | 0.250 |
Why?
|
Up-Regulation | 7 | 2015 | 375 | 0.250 |
Why?
|
Caspase 1 | 6 | 2023 | 111 | 0.250 |
Why?
|
Bone Marrow Cells | 3 | 2015 | 237 | 0.240 |
Why?
|
Disease Resistance | 1 | 2025 | 24 | 0.230 |
Why?
|
Vaccines, DNA | 3 | 2014 | 98 | 0.230 |
Why?
|
HIV Envelope Protein gp120 | 3 | 2015 | 133 | 0.230 |
Why?
|
Interferon-beta | 3 | 2014 | 80 | 0.220 |
Why?
|
Gram-Negative Bacteria | 2 | 2018 | 57 | 0.220 |
Why?
|
Microglia | 3 | 2021 | 238 | 0.220 |
Why?
|
Interferons | 1 | 2024 | 74 | 0.220 |
Why?
|
Disease Models, Animal | 7 | 2021 | 2173 | 0.220 |
Why?
|
Fibroblasts | 2 | 2016 | 392 | 0.200 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2010 | 125 | 0.200 |
Why?
|
Immunoglobulin G | 2 | 2015 | 463 | 0.200 |
Why?
|
Epithelial Cells | 2 | 2024 | 389 | 0.200 |
Why?
|
Hepatitis | 1 | 2023 | 56 | 0.200 |
Why?
|
Islets of Langerhans | 2 | 2018 | 279 | 0.200 |
Why?
|
Intestinal Mucosa | 1 | 2024 | 242 | 0.200 |
Why?
|
Schiff Bases | 1 | 2001 | 1 | 0.190 |
Why?
|
Semicarbazides | 1 | 2001 | 2 | 0.190 |
Why?
|
Toll-Like Receptor 9 | 6 | 2013 | 211 | 0.190 |
Why?
|
Models, Biological | 4 | 2016 | 1180 | 0.190 |
Why?
|
Cell Line | 13 | 2010 | 2038 | 0.190 |
Why?
|
Ventricular Remodeling | 2 | 2020 | 83 | 0.190 |
Why?
|
Hepatitis, Alcoholic | 1 | 2023 | 77 | 0.190 |
Why?
|
Influenza A virus | 1 | 2023 | 123 | 0.190 |
Why?
|
Lysosomes | 5 | 2014 | 167 | 0.180 |
Why?
|
T-Lymphocytes | 5 | 2014 | 1005 | 0.180 |
Why?
|
Endosomes | 3 | 2014 | 178 | 0.180 |
Why?
|
Th1 Cells | 3 | 2015 | 175 | 0.180 |
Why?
|
Cholesterol | 2 | 2014 | 259 | 0.170 |
Why?
|
Interferon-gamma | 6 | 2020 | 567 | 0.170 |
Why?
|
Proteolysis | 2 | 2019 | 145 | 0.170 |
Why?
|
Myocardium | 2 | 2020 | 275 | 0.170 |
Why?
|
Adaptor Proteins, Signal Transducing | 6 | 2023 | 427 | 0.170 |
Why?
|
Th2 Cells | 2 | 2015 | 98 | 0.170 |
Why?
|
Malaria, Cerebral | 1 | 2020 | 23 | 0.170 |
Why?
|
Complement C3 | 2 | 2020 | 59 | 0.170 |
Why?
|
Interferon Regulatory Factor-3 | 4 | 2014 | 97 | 0.170 |
Why?
|
Influenza, Human | 1 | 2023 | 206 | 0.170 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2011 | 149 | 0.160 |
Why?
|
Acyltransferases | 3 | 2009 | 31 | 0.160 |
Why?
|
Angiotensin II | 1 | 2020 | 26 | 0.160 |
Why?
|
Inflammation Mediators | 3 | 2010 | 176 | 0.160 |
Why?
|
Macrophage Activation | 5 | 2018 | 119 | 0.160 |
Why?
|
Non-alcoholic Fatty Liver Disease | 1 | 2020 | 83 | 0.160 |
Why?
|
Streptolysins | 1 | 2019 | 10 | 0.160 |
Why?
|
Streptococcus pyogenes | 1 | 2019 | 31 | 0.160 |
Why?
|
Type III Secretion Systems | 1 | 2018 | 4 | 0.150 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2020 | 87 | 0.150 |
Why?
|
Streptococcal Infections | 1 | 2019 | 79 | 0.150 |
Why?
|
Immunity | 1 | 2019 | 107 | 0.150 |
Why?
|
Multiple Sclerosis | 1 | 2021 | 217 | 0.150 |
Why?
|
CARD Signaling Adaptor Proteins | 5 | 2023 | 67 | 0.150 |
Why?
|
Endocytosis | 3 | 2014 | 152 | 0.140 |
Why?
|
Sepsis | 1 | 2002 | 279 | 0.140 |
Why?
|
Monocytes | 6 | 2020 | 353 | 0.140 |
Why?
|
Pneumonia, Bacterial | 2 | 2016 | 89 | 0.140 |
Why?
|
Escherichia coli Proteins | 3 | 2009 | 270 | 0.130 |
Why?
|
Palmitates | 1 | 2016 | 21 | 0.130 |
Why?
|
Interleukin-6 | 7 | 2020 | 319 | 0.130 |
Why?
|
Disease | 1 | 2016 | 27 | 0.130 |
Why?
|
Astrocytes | 2 | 2015 | 119 | 0.130 |
Why?
|
HIV Antibodies | 2 | 2014 | 144 | 0.130 |
Why?
|
Oxidative Stress | 1 | 2018 | 293 | 0.130 |
Why?
|
Phagocytosis | 3 | 2010 | 264 | 0.130 |
Why?
|
Down-Regulation | 2 | 2010 | 318 | 0.130 |
Why?
|
Bacteria | 2 | 2016 | 305 | 0.130 |
Why?
|
Klebsiella Infections | 1 | 2016 | 22 | 0.130 |
Why?
|
Klebsiella pneumoniae | 1 | 2016 | 28 | 0.130 |
Why?
|
Parvovirus | 2 | 2007 | 24 | 0.130 |
Why?
|
Antineoplastic Agents | 1 | 2001 | 660 | 0.130 |
Why?
|
Mammary Tumor Virus, Mouse | 1 | 2015 | 7 | 0.120 |
Why?
|
Cellular Senescence | 1 | 2016 | 110 | 0.120 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2015 | 9 | 0.120 |
Why?
|
GTP-Binding Proteins | 1 | 2015 | 82 | 0.120 |
Why?
|
Solubility | 1 | 2015 | 178 | 0.120 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2016 | 206 | 0.120 |
Why?
|
Cytoskeletal Proteins | 3 | 2013 | 200 | 0.120 |
Why?
|
HEK293 Cells | 2 | 2014 | 618 | 0.120 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2014 | 5 | 0.120 |
Why?
|
Chemokine CCL4 | 1 | 2014 | 14 | 0.120 |
Why?
|
Chemokine CCL5 | 1 | 2014 | 33 | 0.120 |
Why?
|
RNA, Messenger | 7 | 2020 | 1528 | 0.120 |
Why?
|
Viral Envelope Proteins | 1 | 2015 | 102 | 0.120 |
Why?
|
Mice, Inbred C3H | 5 | 2010 | 176 | 0.120 |
Why?
|
Aluminum Hydroxide | 1 | 2014 | 3 | 0.110 |
Why?
|
Rats | 5 | 2013 | 1977 | 0.110 |
Why?
|
Heart | 1 | 2016 | 282 | 0.110 |
Why?
|
Tumor Necrosis Factor-alpha | 9 | 2011 | 612 | 0.110 |
Why?
|
Phagosomes | 2 | 2014 | 54 | 0.110 |
Why?
|
Immunization, Secondary | 1 | 2014 | 45 | 0.110 |
Why?
|
Hypertension, Pulmonary | 1 | 2015 | 95 | 0.110 |
Why?
|
RNA, Bacterial | 1 | 2014 | 73 | 0.110 |
Why?
|
Cell Survival | 1 | 2015 | 573 | 0.110 |
Why?
|
Hemolysin Proteins | 1 | 2014 | 44 | 0.110 |
Why?
|
Phospholipids | 1 | 2014 | 81 | 0.110 |
Why?
|
Male | 18 | 2024 | 29472 | 0.110 |
Why?
|
Immunization | 1 | 2014 | 133 | 0.110 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2013 | 28 | 0.100 |
Why?
|
Borrelia | 2 | 2010 | 32 | 0.100 |
Why?
|
Toll-Like Receptor 5 | 2 | 2003 | 11 | 0.100 |
Why?
|
rab GTP-Binding Proteins | 2 | 2010 | 80 | 0.100 |
Why?
|
Intestines | 1 | 2013 | 165 | 0.100 |
Why?
|
Ligands | 2 | 2004 | 417 | 0.100 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 147 | 0.100 |
Why?
|
Immunologic Memory | 1 | 2014 | 290 | 0.100 |
Why?
|
HIV-1 | 2 | 2014 | 716 | 0.090 |
Why?
|
Interleukin-12 Subunit p40 | 2 | 2008 | 17 | 0.090 |
Why?
|
Lung | 3 | 2015 | 939 | 0.090 |
Why?
|
Mice, Inbred Strains | 2 | 2013 | 189 | 0.090 |
Why?
|
Neisseria gonorrhoeae | 2 | 2005 | 237 | 0.090 |
Why?
|
Heart Ventricles | 1 | 2013 | 261 | 0.090 |
Why?
|
Obesity | 1 | 2019 | 1230 | 0.090 |
Why?
|
Brain | 2 | 2020 | 1550 | 0.090 |
Why?
|
RNA Stability | 1 | 2011 | 102 | 0.090 |
Why?
|
Flow Cytometry | 4 | 2010 | 669 | 0.090 |
Why?
|
Shock, Septic | 2 | 2010 | 86 | 0.090 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2010 | 10 | 0.090 |
Why?
|
Toxoplasmosis, Animal | 1 | 2010 | 10 | 0.090 |
Why?
|
CpG Islands | 3 | 2010 | 216 | 0.090 |
Why?
|
Relapsing Fever | 1 | 2010 | 17 | 0.090 |
Why?
|
Ki-67 Antigen | 1 | 2010 | 37 | 0.090 |
Why?
|
Tamoxifen | 1 | 2010 | 41 | 0.080 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2010 | 35 | 0.080 |
Why?
|
Chlamydophila pneumoniae | 1 | 2010 | 21 | 0.080 |
Why?
|
Antibody Formation | 1 | 2010 | 112 | 0.080 |
Why?
|
Lymphocyte Activation | 2 | 2010 | 759 | 0.080 |
Why?
|
Female | 16 | 2024 | 32478 | 0.080 |
Why?
|
Acute Lung Injury | 1 | 2010 | 45 | 0.080 |
Why?
|
Antibodies, Bacterial | 2 | 2010 | 194 | 0.080 |
Why?
|
Receptors, Estrogen | 1 | 2010 | 128 | 0.080 |
Why?
|
Membrane Transport Proteins | 1 | 2010 | 131 | 0.080 |
Why?
|
Chlamydia Infections | 1 | 2010 | 76 | 0.080 |
Why?
|
Early Growth Response Protein 1 | 1 | 2009 | 15 | 0.080 |
Why?
|
Cell Membrane | 4 | 2008 | 493 | 0.080 |
Why?
|
Enzyme Activation | 3 | 2020 | 380 | 0.080 |
Why?
|
Boutonneuse Fever | 1 | 2008 | 1 | 0.080 |
Why?
|
Rickettsia Infections | 1 | 2008 | 1 | 0.080 |
Why?
|
Insect Bites and Stings | 1 | 2008 | 2 | 0.080 |
Why?
|
Rats, Inbred BB | 1 | 2009 | 134 | 0.080 |
Why?
|
Diet, High-Fat | 2 | 2020 | 174 | 0.080 |
Why?
|
Bacterial Vaccines | 1 | 2009 | 87 | 0.080 |
Why?
|
Diabetes Mellitus | 1 | 2013 | 536 | 0.080 |
Why?
|
In Vitro Techniques | 4 | 2020 | 487 | 0.080 |
Why?
|
Atherosclerosis | 1 | 2010 | 152 | 0.070 |
Why?
|
Teichoic Acids | 1 | 2008 | 13 | 0.070 |
Why?
|
Cell Adhesion Molecules | 1 | 2008 | 89 | 0.070 |
Why?
|
Liver | 3 | 2020 | 843 | 0.070 |
Why?
|
Chemokines | 1 | 2008 | 95 | 0.070 |
Why?
|
CD36 Antigens | 1 | 2008 | 26 | 0.070 |
Why?
|
Trypanosoma cruzi | 1 | 2008 | 51 | 0.070 |
Why?
|
Mice, Inbred BALB C | 4 | 2014 | 893 | 0.070 |
Why?
|
Neutrophils | 2 | 2016 | 376 | 0.070 |
Why?
|
Mice, Inbred NOD | 1 | 2009 | 521 | 0.070 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 2007 | 34 | 0.070 |
Why?
|
HIV Infections | 2 | 2004 | 962 | 0.070 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2008 | 164 | 0.070 |
Why?
|
B-Lymphocytes | 2 | 2007 | 569 | 0.070 |
Why?
|
Immunoglobulin M | 1 | 2007 | 116 | 0.070 |
Why?
|
CHO Cells | 3 | 2002 | 190 | 0.070 |
Why?
|
Health | 1 | 2007 | 31 | 0.070 |
Why?
|
Endoplasmic Reticulum | 2 | 2008 | 173 | 0.070 |
Why?
|
Spleen | 3 | 2020 | 482 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2009 | 213 | 0.070 |
Why?
|
Oligodeoxyribonucleotides | 2 | 2008 | 245 | 0.070 |
Why?
|
Rhinovirus | 1 | 2006 | 4 | 0.070 |
Why?
|
Poly I-C | 3 | 2013 | 76 | 0.070 |
Why?
|
Cricetinae | 3 | 2002 | 368 | 0.070 |
Why?
|
Cell Movement | 1 | 2008 | 445 | 0.070 |
Why?
|
Antigens, Bacterial | 1 | 2007 | 207 | 0.060 |
Why?
|
Myocardial Infarction | 1 | 2013 | 910 | 0.060 |
Why?
|
Complement C4b-Binding Protein | 1 | 2005 | 34 | 0.060 |
Why?
|
Golgi Apparatus | 2 | 2003 | 64 | 0.060 |
Why?
|
Interleukin-1 | 4 | 2010 | 153 | 0.060 |
Why?
|
Fibrosis | 2 | 2020 | 159 | 0.060 |
Why?
|
Interleukin-8 | 2 | 2003 | 88 | 0.060 |
Why?
|
Parvoviridae Infections | 1 | 2005 | 23 | 0.060 |
Why?
|
Antigens, Surface | 2 | 2002 | 196 | 0.060 |
Why?
|
Interleukin-10 | 3 | 2015 | 159 | 0.060 |
Why?
|
Cell Wall | 2 | 2003 | 118 | 0.060 |
Why?
|
Bacteroidaceae Infections | 1 | 2004 | 3 | 0.060 |
Why?
|
Porphyromonas gingivalis | 1 | 2004 | 17 | 0.060 |
Why?
|
Arteriosclerosis | 1 | 2004 | 30 | 0.060 |
Why?
|
Dimerization | 3 | 2009 | 145 | 0.060 |
Why?
|
Neurodegenerative Diseases | 1 | 2006 | 139 | 0.060 |
Why?
|
Periodontitis | 1 | 2004 | 15 | 0.060 |
Why?
|
Regeneration | 1 | 2024 | 96 | 0.050 |
Why?
|
Vaccination | 1 | 2006 | 352 | 0.050 |
Why?
|
Signaling Lymphocytic Activation Molecule Family | 1 | 2023 | 5 | 0.050 |
Why?
|
Colitis | 1 | 2024 | 77 | 0.050 |
Why?
|
Organ Size | 2 | 2020 | 171 | 0.050 |
Why?
|
Neutrophil Activation | 1 | 2023 | 24 | 0.050 |
Why?
|
Transfection | 5 | 2003 | 691 | 0.050 |
Why?
|
Gonorrhea | 1 | 2005 | 186 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2024 | 100 | 0.050 |
Why?
|
Burns | 1 | 2003 | 41 | 0.050 |
Why?
|
Fluorescence Recovery After Photobleaching | 1 | 2003 | 24 | 0.050 |
Why?
|
DNA-Binding Proteins | 3 | 2004 | 1184 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2002 | 861 | 0.050 |
Why?
|
Measles virus | 1 | 2002 | 2 | 0.050 |
Why?
|
Hemagglutinins, Viral | 1 | 2002 | 12 | 0.050 |
Why?
|
Escherichia coli | 4 | 2010 | 708 | 0.050 |
Why?
|
Hexuronic Acids | 1 | 2002 | 22 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 453 | 0.050 |
Why?
|
Gene Expression | 2 | 2016 | 836 | 0.050 |
Why?
|
Cushing Syndrome | 1 | 2002 | 6 | 0.050 |
Why?
|
Immune System | 1 | 2003 | 130 | 0.050 |
Why?
|
Cardiopulmonary Bypass | 1 | 2002 | 56 | 0.050 |
Why?
|
Cervix Uteri | 1 | 2002 | 56 | 0.050 |
Why?
|
Disease Susceptibility | 2 | 2016 | 166 | 0.050 |
Why?
|
Vagina | 1 | 2002 | 82 | 0.050 |
Why?
|
Protein Isoforms | 1 | 2002 | 199 | 0.050 |
Why?
|
Growth Inhibitors | 1 | 2001 | 26 | 0.050 |
Why?
|
Toll-Like Receptor 8 | 1 | 2002 | 48 | 0.050 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2001 | 82 | 0.050 |
Why?
|
Biopolymers | 1 | 2002 | 70 | 0.050 |
Why?
|
Inhibitory Concentration 50 | 1 | 2001 | 89 | 0.050 |
Why?
|
Protein Binding | 3 | 2015 | 1601 | 0.050 |
Why?
|
3T3 Cells | 1 | 2001 | 110 | 0.050 |
Why?
|
Reactive Oxygen Species | 1 | 2002 | 224 | 0.050 |
Why?
|
Mammals | 1 | 2003 | 217 | 0.050 |
Why?
|
Biomarkers | 3 | 2020 | 1382 | 0.050 |
Why?
|
Breast Neoplasms | 1 | 2010 | 1193 | 0.050 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2002 | 78 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2002 | 189 | 0.040 |
Why?
|
Bone and Bones | 1 | 2002 | 142 | 0.040 |
Why?
|
Microscopy, Confocal | 3 | 2010 | 234 | 0.040 |
Why?
|
Tumor Cells, Cultured | 1 | 2001 | 454 | 0.040 |
Why?
|
Disease Progression | 2 | 2021 | 1159 | 0.040 |
Why?
|
Heat Shock Transcription Factors | 1 | 2020 | 12 | 0.040 |
Why?
|
Plasmodium chabaudi | 1 | 2020 | 29 | 0.040 |
Why?
|
Benzoquinones | 1 | 2020 | 14 | 0.040 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 2020 | 19 | 0.040 |
Why?
|
Lactams, Macrocyclic | 1 | 2020 | 25 | 0.040 |
Why?
|
Hypertrophy | 1 | 2020 | 30 | 0.040 |
Why?
|
Cell Division | 1 | 2001 | 450 | 0.040 |
Why?
|
Cardiomegaly | 1 | 2020 | 34 | 0.040 |
Why?
|
Coronary Artery Bypass | 1 | 2002 | 297 | 0.040 |
Why?
|
Drosophila | 1 | 2003 | 430 | 0.040 |
Why?
|
Ethanol | 1 | 2023 | 321 | 0.040 |
Why?
|
Systole | 1 | 2020 | 109 | 0.040 |
Why?
|
Peptides | 1 | 2023 | 573 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2004 | 866 | 0.040 |
Why?
|
Extracellular Matrix | 1 | 2020 | 139 | 0.040 |
Why?
|
Myocytes, Cardiac | 1 | 2020 | 96 | 0.040 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2020 | 65 | 0.040 |
Why?
|
Neisseria meningitidis | 1 | 2000 | 81 | 0.040 |
Why?
|
Hepatocytes | 1 | 2020 | 215 | 0.040 |
Why?
|
Luminescent Proteins | 3 | 2004 | 128 | 0.040 |
Why?
|
Ubiquitination | 1 | 2019 | 111 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 283 | 0.040 |
Why?
|
src-Family Kinases | 2 | 2010 | 63 | 0.040 |
Why?
|
Middle Aged | 6 | 2020 | 17358 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2002 | 308 | 0.040 |
Why?
|
Drosophila melanogaster | 1 | 2002 | 488 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 231 | 0.030 |
Why?
|
Time Factors | 3 | 2013 | 3740 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 3 | 2004 | 495 | 0.030 |
Why?
|
Blood Pressure | 1 | 2020 | 513 | 0.030 |
Why?
|
Chemokine CXCL2 | 1 | 2016 | 14 | 0.030 |
Why?
|
Insulin-Secreting Cells | 1 | 2018 | 190 | 0.030 |
Why?
|
Cell Separation | 2 | 2010 | 147 | 0.030 |
Why?
|
Panax | 1 | 1996 | 2 | 0.030 |
Why?
|
MAP Kinase Signaling System | 2 | 2011 | 225 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 544 | 0.030 |
Why?
|
beta-Galactosidase | 1 | 2016 | 77 | 0.030 |
Why?
|
Vaccines, Attenuated | 2 | 2009 | 36 | 0.030 |
Why?
|
Plants, Medicinal | 1 | 1996 | 61 | 0.030 |
Why?
|
Mice, Mutant Strains | 2 | 2010 | 302 | 0.030 |
Why?
|
Mice, Obese | 1 | 2016 | 80 | 0.030 |
Why?
|
Recombinant Proteins | 2 | 2009 | 700 | 0.030 |
Why?
|
Insulin Resistance | 1 | 2019 | 409 | 0.030 |
Why?
|
Base Sequence | 2 | 2011 | 1333 | 0.030 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2015 | 7 | 0.030 |
Why?
|
Molecular Sequence Data | 2 | 2011 | 1992 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 2015 | 42 | 0.030 |
Why?
|
Insulin | 1 | 2019 | 687 | 0.030 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2015 | 48 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2015 | 236 | 0.030 |
Why?
|
Toll-Like Receptor 1 | 2 | 2007 | 22 | 0.030 |
Why?
|
Polysaccharides | 1 | 1996 | 142 | 0.030 |
Why?
|
Immune Evasion | 1 | 2015 | 69 | 0.030 |
Why?
|
Protein Structure, Tertiary | 2 | 2009 | 670 | 0.030 |
Why?
|
Leukocytes | 1 | 2015 | 103 | 0.030 |
Why?
|
Collagen | 1 | 2015 | 127 | 0.030 |
Why?
|
Arteries | 1 | 2015 | 81 | 0.030 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2004 | 95 | 0.030 |
Why?
|
Species Specificity | 2 | 2005 | 334 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 2 | 2008 | 240 | 0.030 |
Why?
|
Vaccines, Subunit | 1 | 2014 | 40 | 0.030 |
Why?
|
Drug Combinations | 1 | 2014 | 152 | 0.030 |
Why?
|
Adult | 4 | 2020 | 16623 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 376 | 0.030 |
Why?
|
Rabbits | 1 | 2014 | 332 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2015 | 888 | 0.030 |
Why?
|
Myocardial Contraction | 1 | 2013 | 88 | 0.030 |
Why?
|
Potassium | 1 | 2013 | 101 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2013 | 185 | 0.020 |
Why?
|
Blotting, Western | 2 | 2005 | 610 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2014 | 207 | 0.020 |
Why?
|
Regulatory Sequences, Ribonucleic Acid | 1 | 2011 | 9 | 0.020 |
Why?
|
Half-Life | 1 | 2011 | 77 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2011 | 92 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2013 | 292 | 0.020 |
Why?
|
CD18 Antigens | 2 | 2002 | 30 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2013 | 268 | 0.020 |
Why?
|
Green Fluorescent Proteins | 2 | 2003 | 364 | 0.020 |
Why?
|
Nod2 Signaling Adaptor Protein | 1 | 2010 | 26 | 0.020 |
Why?
|
Diet, Atherogenic | 1 | 2010 | 7 | 0.020 |
Why?
|
Tumor Burden | 1 | 2010 | 67 | 0.020 |
Why?
|
Peritoneal Cavity | 1 | 2010 | 31 | 0.020 |
Why?
|
Cathepsin L | 1 | 2010 | 21 | 0.020 |
Why?
|
Cathepsin B | 1 | 2010 | 13 | 0.020 |
Why?
|
Toxoplasma | 1 | 2010 | 33 | 0.020 |
Why?
|
Receptors, LDL | 1 | 2010 | 34 | 0.020 |
Why?
|
Activating Transcription Factor 3 | 1 | 2010 | 7 | 0.020 |
Why?
|
Receptor, ErbB-2 | 1 | 2010 | 55 | 0.020 |
Why?
|
Immunoblotting | 1 | 2010 | 204 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2010 | 39 | 0.020 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2010 | 27 | 0.020 |
Why?
|
Pulmonary Alveoli | 1 | 2010 | 41 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2010 | 233 | 0.020 |
Why?
|
Interleukin-12 | 1 | 2010 | 128 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2010 | 110 | 0.020 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2010 | 93 | 0.020 |
Why?
|
Phagocytes | 1 | 2010 | 52 | 0.020 |
Why?
|
Crystallization | 1 | 2010 | 99 | 0.020 |
Why?
|
Interferon Regulatory Factors | 1 | 2010 | 43 | 0.020 |
Why?
|
Molecular Weight | 1 | 2010 | 188 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2010 | 82 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2010 | 139 | 0.020 |
Why?
|
Young Adult | 1 | 2020 | 4633 | 0.020 |
Why?
|
Macrophages, Alveolar | 1 | 2010 | 64 | 0.020 |
Why?
|
Antigen-Presenting Cells | 1 | 2010 | 178 | 0.020 |
Why?
|
Leukosialin | 1 | 2009 | 2 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2010 | 126 | 0.020 |
Why?
|
Administration, Intranasal | 1 | 2009 | 28 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2010 | 272 | 0.020 |
Why?
|
Hyaluronan Receptors | 1 | 2009 | 35 | 0.020 |
Why?
|
Bacteremia | 1 | 2010 | 94 | 0.020 |
Why?
|
Hyaluronic Acid | 1 | 2010 | 67 | 0.020 |
Why?
|
Colony Count, Microbial | 1 | 2009 | 60 | 0.020 |
Why?
|
ets-Domain Protein Elk-1 | 1 | 2009 | 5 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2010 | 177 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2009 | 247 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 416 | 0.020 |
Why?
|
Transcription Factor AP-1 | 1 | 2009 | 41 | 0.020 |
Why?
|
Rickettsieae | 1 | 2008 | 1 | 0.020 |
Why?
|
Siphonaptera | 1 | 2008 | 1 | 0.020 |
Why?
|
Chemokine CCL19 | 1 | 2008 | 2 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 1350 | 0.020 |
Why?
|
Insect Vectors | 1 | 2008 | 15 | 0.020 |
Why?
|
Ticks | 1 | 2008 | 35 | 0.020 |
Why?
|
Dynamin I | 1 | 2008 | 1 | 0.020 |
Why?
|
Acetylation | 1 | 2008 | 121 | 0.020 |
Why?
|
trans-Golgi Network | 1 | 2008 | 8 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2010 | 726 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2010 | 738 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2010 | 337 | 0.020 |
Why?
|
Cell Compartmentation | 1 | 2008 | 36 | 0.020 |
Why?
|
Retroelements | 1 | 2008 | 43 | 0.020 |
Why?
|
Host-Parasite Interactions | 1 | 2008 | 58 | 0.020 |
Why?
|
Opsonin Proteins | 1 | 2008 | 31 | 0.020 |
Why?
|
Hot Temperature | 1 | 2008 | 130 | 0.020 |
Why?
|
Survival Analysis | 1 | 2009 | 576 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2009 | 248 | 0.020 |
Why?
|
Aged | 2 | 2020 | 14249 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 1077 | 0.020 |
Why?
|
Biological Transport | 1 | 2008 | 292 | 0.020 |
Why?
|
Lipids | 1 | 2009 | 316 | 0.020 |
Why?
|
Borrelia Infections | 1 | 2007 | 12 | 0.020 |
Why?
|
Breeding | 1 | 2007 | 26 | 0.020 |
Why?
|
Chloroquine | 1 | 2007 | 54 | 0.020 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2007 | 60 | 0.020 |
Why?
|
Biomarkers, Tumor | 1 | 2010 | 502 | 0.020 |
Why?
|
Dogs | 1 | 2008 | 324 | 0.020 |
Why?
|
STAT1 Transcription Factor | 1 | 2006 | 35 | 0.020 |
Why?
|
Oligodendroglia | 1 | 2006 | 36 | 0.020 |
Why?
|
RNA Interference | 1 | 2010 | 618 | 0.020 |
Why?
|
Genome, Viral | 1 | 2007 | 133 | 0.020 |
Why?
|
DNA, Viral | 1 | 2007 | 231 | 0.020 |
Why?
|
Pan troglodytes | 1 | 2005 | 34 | 0.020 |
Why?
|
Prognosis | 1 | 2010 | 1724 | 0.020 |
Why?
|
Blood Bactericidal Activity | 1 | 2005 | 66 | 0.020 |
Why?
|
Porins | 1 | 2005 | 70 | 0.020 |
Why?
|
Parvoviridae | 1 | 2005 | 5 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 761 | 0.010 |
Why?
|
CD4-CD8 Ratio | 1 | 2004 | 16 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2005 | 298 | 0.010 |
Why?
|
Vaccinia | 1 | 2005 | 32 | 0.010 |
Why?
|
HeLa Cells | 1 | 2006 | 532 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2010 | 2445 | 0.010 |
Why?
|
Oxidoreductases | 1 | 2005 | 64 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2006 | 621 | 0.010 |
Why?
|
Interleukins | 1 | 2005 | 80 | 0.010 |
Why?
|
Macaca mulatta | 1 | 2005 | 248 | 0.010 |
Why?
|
Vaccinia virus | 1 | 2005 | 71 | 0.010 |
Why?
|
Fimbriae, Bacterial | 1 | 2004 | 19 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 2004 | 93 | 0.010 |
Why?
|
Biological Transport, Active | 1 | 2004 | 37 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2004 | 138 | 0.010 |
Why?
|
Apolipoproteins E | 1 | 2004 | 109 | 0.010 |
Why?
|
Allergens | 1 | 2003 | 52 | 0.010 |
Why?
|
Antigens, Ly | 1 | 2003 | 42 | 0.010 |
Why?
|
Chimera | 1 | 2003 | 42 | 0.010 |
Why?
|
Mice, Nude | 1 | 2003 | 271 | 0.010 |
Why?
|
Brefeldin A | 1 | 2002 | 7 | 0.010 |
Why?
|
Membrane Cofactor Protein | 1 | 2002 | 1 | 0.010 |
Why?
|
Measles Vaccine | 1 | 2002 | 2 | 0.010 |
Why?
|
CD11b Antigen | 1 | 2002 | 19 | 0.010 |
Why?
|
Intracellular Fluid | 1 | 2002 | 32 | 0.010 |
Why?
|
Drug Design | 1 | 2003 | 136 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2002 | 77 | 0.010 |
Why?
|
Culture Media | 1 | 2003 | 79 | 0.010 |
Why?
|
Virus Replication | 1 | 2004 | 318 | 0.010 |
Why?
|
Streptococcus pneumoniae | 1 | 2002 | 66 | 0.010 |
Why?
|
Luciferases | 1 | 2002 | 109 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2005 | 1594 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2002 | 99 | 0.010 |
Why?
|
Immunity, Mucosal | 1 | 2002 | 52 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2002 | 256 | 0.010 |
Why?
|
Hormones | 1 | 2002 | 60 | 0.010 |
Why?
|
Kinetics | 1 | 2003 | 764 | 0.010 |
Why?
|
Plasmids | 1 | 2002 | 292 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2002 | 239 | 0.010 |
Why?
|
Postoperative Period | 1 | 2002 | 138 | 0.010 |
Why?
|
Bone Density | 1 | 2002 | 134 | 0.010 |
Why?
|
Antigens, CD | 1 | 2002 | 348 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2004 | 1108 | 0.010 |
Why?
|
Protein Transport | 1 | 2002 | 402 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2002 | 400 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2002 | 198 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2007 | 889 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2004 | 1247 | 0.010 |
Why?
|
Hydrocortisone | 1 | 2002 | 192 | 0.010 |
Why?
|
Neurons | 1 | 2006 | 909 | 0.010 |
Why?
|
Kidney | 1 | 2003 | 444 | 0.010 |
Why?
|
CD11 Antigens | 1 | 1999 | 16 | 0.010 |
Why?
|
Endotoxins | 1 | 1999 | 80 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2004 | 2540 | 0.010 |
Why?
|
Complement Inactivator Proteins | 1 | 1996 | 9 | 0.010 |
Why?
|
Interferon Type I | 1 | 1996 | 186 | 0.010 |
Why?
|
Mutation | 1 | 2000 | 2573 | 0.010 |
Why?
|